Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences
Open Access
- 16 June 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 80 (5), e63
- https://doi.org/10.1136/annrheumdis-2020-218183
Abstract
No abstract availableKeywords
Funding Information
- Key Foundation of Wuhan Huoshenshan Hospital (2020[18])
- Medical Innovation Project of Logistics Service (18JS005)
- Key Research& Development Program of Jiangsu Province (BE2018713)
This publication has 7 references indexed in Scilit:
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'Annals Of The Rheumatic Diseases, 2020
- SAT0409 BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOPATHY REDUCES SICKNOTES ISSUED BY GPS, DESPITE DELAYS IN DIAGNOSIS: A REAL-LIFE STUDY IN WALES.Annals Of The Rheumatic Diseases, 2020
- Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’Annals Of The Rheumatic Diseases, 2020
- Response to: ‘Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpouret alAnnals Of The Rheumatic Diseases, 2020
- Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trialPhytomedicine, 2020
- Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquineAnnals Of The Rheumatic Diseases, 2020